chr6-123273341-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006073.4(TRDN):​c.1620A>G​(p.Ile540Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00714 in 1,054,006 control chromosomes in the GnomAD database, including 238 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 69 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 169 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.662

Publications

8 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018236339).
BP6
Variant 6-123273341-T-C is Benign according to our data. Variant chr6-123273341-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 227115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.071 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.1620A>G p.Ile540Met missense_variant Exon 28 of 41 ENST00000334268.9 NP_006064.2 Q13061-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.1620A>G p.Ile540Met missense_variant Exon 28 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1

Frequencies

GnomAD3 genomes
AF:
0.0173
AC:
2619
AN:
151062
Hom.:
68
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0443
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00557
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.0339
Gnomad SAS
AF:
0.0777
Gnomad FIN
AF:
0.00692
Gnomad MID
AF:
0.0130
Gnomad NFE
AF:
0.000944
Gnomad OTH
AF:
0.0135
GnomAD2 exomes
AF:
0.0151
AC:
1201
AN:
79470
AF XY:
0.0185
show subpopulations
Gnomad AFR exome
AF:
0.0447
Gnomad AMR exome
AF:
0.00340
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.0412
Gnomad FIN exome
AF:
0.00591
Gnomad NFE exome
AF:
0.000703
Gnomad OTH exome
AF:
0.00549
GnomAD4 exome
AF:
0.00543
AC:
4906
AN:
902826
Hom.:
169
Cov.:
13
AF XY:
0.00749
AC XY:
3379
AN XY:
451238
show subpopulations
African (AFR)
AF:
0.0304
AC:
524
AN:
17228
American (AMR)
AF:
0.00272
AC:
30
AN:
11014
Ashkenazi Jewish (ASJ)
AF:
0.000464
AC:
8
AN:
17236
East Asian (EAS)
AF:
0.0155
AC:
252
AN:
16290
South Asian (SAS)
AF:
0.0618
AC:
3374
AN:
54612
European-Finnish (FIN)
AF:
0.00503
AC:
164
AN:
32618
Middle Eastern (MID)
AF:
0.00704
AC:
29
AN:
4120
European-Non Finnish (NFE)
AF:
0.000402
AC:
286
AN:
712074
Other (OTH)
AF:
0.00635
AC:
239
AN:
37634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
171
343
514
686
857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0173
AC:
2618
AN:
151180
Hom.:
69
Cov.:
32
AF XY:
0.0190
AC XY:
1405
AN XY:
73816
show subpopulations
African (AFR)
AF:
0.0442
AC:
1833
AN:
41496
American (AMR)
AF:
0.00556
AC:
84
AN:
15110
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3464
East Asian (EAS)
AF:
0.0339
AC:
167
AN:
4922
South Asian (SAS)
AF:
0.0776
AC:
365
AN:
4704
European-Finnish (FIN)
AF:
0.00692
AC:
72
AN:
10412
Middle Eastern (MID)
AF:
0.0105
AC:
3
AN:
286
European-Non Finnish (NFE)
AF:
0.000944
AC:
64
AN:
67772
Other (OTH)
AF:
0.0133
AC:
28
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
116
233
349
466
582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00782
Hom.:
12
Bravo
AF:
0.0162
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.0348
AC:
86
ESP6500EA
AF:
0.000901
AC:
5
ExAC
AF:
0.0228
AC:
690
Asia WGS
AF:
0.0580
AC:
202
AN:
3438

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Oct 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ile540Met in exon 28 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 3.5% (86/2472) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs7771303). -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 25, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Mar 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.087
DANN
Benign
0.84
DEOGEN2
Benign
0.085
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.42
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.66
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.29
N
REVEL
Benign
0.026
Sift
Uncertain
0.025
D
Sift4G
Benign
0.19
T
Polyphen
0.0040
B
Vest4
0.045
ClinPred
0.0041
T
GERP RS
-3.8
Varity_R
0.057
gMVP
0.0031
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7771303; hg19: chr6-123594486; API